Session 160 - 12th CROI

Home

Session 160 Poster Abstracts
HCV Immune Responses
Wednesday, 1:30 - 3:30 pm
Hall B

913	Increased Hepatocyte Fas Expression and Apoptosis in HIV/HCV-co-infected Patients Juan Macías*¹, M Japón², C Sáez², R Palacios¹, N Merchante¹, J Mira¹, J García-García¹, S Vergara¹, F Lozano³, J Gómez-Mateos³, and J Pineda⁴ ¹Hosp Univ de Valme, Seville, Spain; ²Hosp Univ Virgen del Rocío, Seville, Spain; ³Hosp Univ de Valme, Seville, Spain; and ⁴Hosp Univ de Valme, Seville, Spain
914	The Tandem-Repeat Polymorphism of the DC-SIGNR Gene in HCV and HCV/HIV Infection Jacob Nattermann*¹, G Ahlenstiel¹, H Nischalke¹, G Feldmann¹, T Berg², T Sauerbruch¹, J Rockstroh¹, U Spengler¹, and Kompetenznetz HIV/AIDS ¹Univ of Bonn, Germany and ²Humboldt Univ, Berlin, Germany
915	Induction of Effector T-cell Responses following Acute Hepatitis C Virus Infection in HIV-1+ Individuals Arthur Kim*¹, J Timm¹, J Schulze zur Wiesch¹, G Alter¹, M Brockman¹, J Duncan¹, A Jones¹, J Fangman¹, A Wurcel², B McGovern², G Robbins¹, M Addo¹, G Lauer¹, and B Walker¹ ¹Partners AIDS Res Ctr, Massachusetts Gen Hosp, Boston, USA and ²Lemuel Shattuck Hosp, Jamaica Plain, MA, USA
916	HIV Co-infection Impairs CD28 Mediated Co-stimulation of HCV-specific CD8 Cells N Yonkers¹, B Rodriguez^1,2, A Post^2,4, R Asaad^1,2, L Jones³, M Lederman^1,2, P Lehmann¹, and Donald Anthony*^1,3 ¹Case Western Reserve Univ, Ctr For AIDs Res, Cleveland, OH, USA; ²University Hospitals; ³VA Med Ctr, Cleveland, OH, USA; and ⁴Case Western Reserve Univ, Cleveland, OH, USA
917	Sequence Convergence and Cellular Immune Escape during Acute Human Hepatitis C Andrea Cox*, Q Mao, T Mosbruger, D Netski, X H Wang, D Pardoll, D Thomas, and S Ray Johns Hopkins Univ, Baltimore, MD, USA
918	Neutralizing Antibodies in Acute and Early Hepatitis C Virus Infection Dale Netski*¹, J McKeating², K Dowd¹, D Thomas¹, and S Ray¹ ¹Johns Hopkins Univ Sch of Med, Baltimore, MD, USA and ²Rockefeller Univ, New York, NY, USA
919	Role of MHC Class I-associated Selection Pressures in Influencing HCV Evolution Joerg Timm*^1,5,6, A Kim^1,5,6, L Reyor^1,5,6, G Lauer^1,5,6, R Allgaier^1,5,6, R Gandhi^5,6, R Chung^3,6, P Klenerman⁴, B Walker^1,5,6, and T Allen^1,5,6 ¹Howard Hughes Med Inst, Boston, MA, USA; ³Massachusetts Gen Hosp, Boston, USA; ⁴Univ of Oxford, UK; ⁵Partners AIDS Res Ctr, Massachusetts Gen Hosp, Boston, USA; and ⁶Harvard Med Sch, Boston, MA, USA
920	Differential Effects of Ethanol Consumption on Antigen-specific Cellular Immune Responses in HIV/HCV- vs HCV-infected Subjects Camilla Graham*^1,2, A Wells¹, J Murray³, T Herren³, S Tumilty⁴, S Stuver³, D Craven⁵, D Nunes⁴, R Horsburgh^4,6, and M Koziel^1,2 ¹Beth Israel Deaconess Med Ctr, Boston, MA, USA; ²Harvard Med Sch, Boston, MA, USA; ³Boston Univ, MA, USA; ⁴Boston Med Ctr, MA, USA; ⁵Lahey Clin Med Ctr, Burlington, MA, USA; and ⁶Boston Univ, MA, USA
921	Effect of Human Herpesvirus 8 and Hepatitis C Virus Co-infection on T-cell Activation among HIV-infected Patients Peter Hunt*, S Deeks, A Graves-Jones, E Sinclair, B Bredt, and J Martin Univ of California, San Francisco, USA